Corey McCann is the cofounder and CEO of Pear Therapeutics which is a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals. The company has raised over $250 million from investors such as Temasek Holdings, 5AM Ventures, Softbank Vision Fund, EDBI, and Trustbridge Partners to name a few. 

In this episode, you will learn:

Corey McCann’s top advice for other entrepreneurs
The Pareto Principle 
Mastering fundraising from an investor’s perspective

Alejandro Cremades · EP 297 Corey McCann On Raising $250 Million To Create Software As A Drug
SUBSCRIBE ON:

For a winning deck, take a look at the pitch deck template created by Silicon Valley legend, Peter Thiel (see it here) that I recently covered. Thiel was the first angel investor in Facebook with a $500K check that turned into more than $1 billion in cash.

Moreover, I also provided a commentary on a pitch deck from an Uber competitor that has raised over $400 million (see it here).

Remember to unlock for free the pitch deck template that is being used by founders around the world to raise millions below.

About Corey McCann:
Corey M. McCann, MD, PhD, is the President and CEO of Pear Therapeutics, a pioneer in prescription digital therapeutics, as the first company to receive market authorization for software to treat disease.

Previously, Corey McCann was an investor with MPM Capital, where he evaluated new healthcare investment opportunities, managed relationships with strategic partners, and oversaw strategy and execution at portfolio companies.

Prior to MPM, Corey McCann was an Engagement Manager with McKinsey & Company, where he advised pharmaceutical, medical device, and biotechnology companies on the acquisition, development, and commercialization of life science technologies. Corey McCann led McKinsey’s central nervous system expertise group, advising clients across the healthcare value chain.

Corey McCann has previous investment experience with RiverVest Venture Partners, where he performed diligence on early stage investments, and at NeuroInsights, where he evaluated brain-related technologies. Corey McCann is also a co-founder, advisor, or Board Director at AgNovos Healthcare, Alcyone Lifesciences, Dragonfly Sciences, Edumedics,